Phase II Study on Biweekly Combination Therapy of Gemcitabine plus Carboplatin for the Treatment of Elderly Patients with Advanced Non-Small Cell Lung Cancer.
CONCLUSION: This GEM-CBDCA combination administered biweekly showed satisfactory efficacy with mild toxicities in elderly patients with advanced NSCLC.
PMID: 31636145 [PubMed - as supplied by publisher]
Source: The Oncologist - Category: Cancer & Oncology Authors: Takayama K, Ichiki M, Matsumoto T, Ebi N, Akamine S, Tokunaga S, Yamada T, Uchino J, Nakanishi Y Tags: Oncologist Source Type: research
More News: Adenocarcinoma | Anemia | Cancer | Cancer & Oncology | Chemotherapy | Hematology | Lessons | Lung Cancer | Non-Small Cell Lung Cancer | Study | Thrombocytopenia | Toxicology